Novozymes acquires Microbiome Labs and adds a strong position in the North American probiotics market

Acquiring Microbiome Labs is a key step in building Novozymes’ Human Health platform, adding a broad range of proprietary solutions to its existing activities and access to the company’s network of health practitioners.

Novozymes has announced the acquisition of Microbiome Labs. Based in Illinois, US. Microbiome Labs offers a comprehensive portfolio of proprietary probiotic and microbiome solutions and is a vital player in the consumer health industry. The company is delivering double-digit sales growth in 2020, resulting in a revenue of DKK ~250 million (USD ~40 million) with a positive cash flow and an EBIT margin slightly lower than Novozymes’ EBIT margin.

“Within a few years, Microbiome Labs has built a solid market position and become a key opinion leader on the microbiome in the consumer health industry, and I am very happy to welcome Microbiome Labs to the Novozymes family. With its solid product portfolio and position with health practitioners, the company is a natural fit and matches our strategy of winning through scientifically proven solutions with specific health benefits,” says Ester Baiget, President and CEO of Novozymes, and continues:

“Probiotics for human use is a selected growth area for Novozymes, and it brings the opportunity of advancing our activities within human health. This is an attractive and relatively young industry and, by acquiring Microbiome Labs, we gain a broader portfolio and a strong position in the North American probiotics market. Combined with our organically developed activities in OneHealth, we ensure a strong foundation for future growth”.

Novozymes has established the brand OneHealth to market solutions within human health under one umbrella. The aim is to help people live healthier and better lives by use of probiotics and enzymes.

“Novozymes is the right home for us. We get global market access and world class science to develop new solutions combining enzymes and probiotics to create clinically-proven solutions that improve human health and well-being,” says Dr. Tom Bayne, CEO at Microbiome Labs.


Innovations in Food (& Beverage) Technology is a quarterly magazine distributed globally both in Print and Digital formats.  Twitter: @Innovfoodtech.  Instagram: @innovationsinfoodtechnology.  Linkedin: